Retour
Fourchette du Jour
22,00 €
22,00 €
Fourchette 52 Semaines
14,87 €
28,06 €
Volume
400
Moyenne 50J / 200J
20,56 €
/
22,44 €
Clôture Précédente
22,00 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,5 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 2,0 | 3,9 |
| Net Margin % | 1,1 | 3,8 |
| Rev Growth 5Y % | 2,2 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
183,03 €
179,43 € – 186,18 €
|
270 B | 1 |
| FY2027 |
115,41 €
113,14 € – 117,40 €
|
260 B | 1 |
| FY2026 |
116,47 €
114,18 € – 118,47 €
|
250 B | 1 |
Points Clés
Revenue grew 2,17% annually over 5 years — modest growth
ROE of 1,97% is below average
Generating 11,65B in free cash flow
P/E of 0,45 — trading at a low valuation
Cash machine — converts 421,95% of earnings into free cash flow
Capital efficient — spends only 4,24% of revenue on capex
Croissance
Revenue Growth (5Y)
2,17%
Revenue (1Y)2,56%
Earnings (1Y)N/A
FCF Growth (3Y)3,63%
Qualité
Return on Equity
1,97%
ROIC0,88%
Net Margin1,14%
Op. Margin1,09%
Sécurité
Debt / Equity
0,63
Current Ratio1,72
Interest Coverage4,47
Valorisation
P/E Ratio
0,45
P/B Ratio0,01
EV/EBITDA17,81
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,56% | Revenue Growth (3Y) | -3,49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -58,03% |
| Revenue Growth (5Y) | 2,17% | Earnings Growth (5Y) | -36,95% |
| Profitability | |||
| Revenue (TTM) | 243,03B | Net Income (TTM) | 2,76B |
| ROE | 1,97% | ROA | 0,99% |
| Gross Margin | 27,65% | Operating Margin | 1,09% |
| Net Margin | 1,14% | Free Cash Flow (TTM) | 11,65B |
| ROIC | 0,88% | FCF Growth (3Y) | 3,63% |
| Safety | |||
| Debt / Equity | 0,63 | Current Ratio | 1,72 |
| Interest Coverage | 4,47 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 0,45 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | -0,34 |
| EV/EBITDA | 17,81 | Dividend Yield | 0,06% |
| Market Cap | 1,25B | Enterprise Value | 47,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 243,03B | 236,95B | 260,91B | 272,94B | 223,02B |
| Net Income | 2,76B | -7,55B | 15,68B | 29,60B | 17,47B |
| EPS (Diluted) | 48,59 | -132,77 | 275,49 | 519,42 | 306,32 |
| Gross Profit | 67,20B | 63,24B | 89,92B | 111,80B | 76,21B |
| Operating Income | 2,64B | -4,04B | 23,38B | 50,49B | 25,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 279,58B | 290,85B | 297,92B | 286,59B | 252,75B |
| Total Liabilities | 142,29B | 148,34B | 147,88B | 146,41B | 137,45B |
| Shareholders' Equity | 137,11B | 142,51B | 150,05B | 140,18B | 115,31B |
| Total Debt | 86,65B | 81,95B | 77,16B | 73,00B | 80,46B |
| Cash & Equivalents | 40,89B | 39,95B | 44,19B | 46,49B | 42,96B |
| Current Assets | 119,14B | 123,22B | 131,85B | 132,54B | 118,01B |
| Current Liabilities | 69,44B | 64,07B | 64,37B | 70,76B | 62,92B |